These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14962221)

  • 1. Role of epsilon amino caproic acid in the management of haemophilic patients with inhibitors.
    Ghosh K; Shetty S; Jijina F; Mohanty D
    Haemophilia; 2004 Jan; 10(1):58-62. PubMed ID: 14962221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epsilon-aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro.
    Ghosh K; Shetty S; Pathare A; Mohanty D
    Acta Haematol; 2000; 103(2):67-72. PubMed ID: 10838448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency.
    Lalwani RB; Stricker RB
    Am J Med Sci; 1992 Jun; 303(6):398-401. PubMed ID: 1605170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry.
    Pasca S; Ambaglio C; Rocino A; Santoro C; Cantori I; Zanon E;
    J Thromb Thrombolysis; 2019 Jan; 47(1):129-133. PubMed ID: 30267246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing perioperative bleeding in patients with inherited bleeding disorders.
    Watterson C; Beacher N
    Evid Based Dent; 2017 Mar; 18(1):28-29. PubMed ID: 28338025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant use of epsilon-aminocaproic acid (Amicar) in the endovascular treatment of cranial arteriovenous fistulae.
    Kallmes DF; Marx WF; Jensen ME; Cloft HJ; Do HM; Lanzino G; West K; Dion JE
    Neuroradiology; 2000 Apr; 42(4):302-8. PubMed ID: 10872177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report.
    Prandota J; Pankow-Prandota L; Kotecki L; Noga L
    Am J Ther; 2001; 8(2):97-107. PubMed ID: 11304663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of inhibitors of fibrinolysis.
    Verstraete M
    Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors.
    Valentino LA
    Haemophilia; 2010 Mar; 16(2):263-71. PubMed ID: 20028421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid reduces bleeding after cardiopulmonary bypass when compared to epsilon aminocaproic acid and placebo.
    Pinosky ML; Kennedy DJ; Fishman RL; Reeves ST; Alpert CC; Ecklund J; Kribbs S; Spinale FG; Kratz JM; Crawford R; Gravlee GP; Dorman BH
    J Card Surg; 1997; 12(5):330-8. PubMed ID: 9635271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
    Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
    J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
    Leipzig TJ; Redelman K; Horner TG
    J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery.
    Williams GD; Bratton SL; Riley EC; Ramamoorthy C
    J Cardiothorac Vasc Anesth; 1999 Jun; 13(3):304-8. PubMed ID: 10392682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients.
    Ghosh K; Shetty S; Kulkarni B
    Haemophilia; 2007 Nov; 13(6):734-9. PubMed ID: 17973850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An examination of aneurysm rerupture rates with epsilon aminocaproic acid.
    Schuette AJ; Hui FK; Obuchowski NA; Walkup RR; Cawley CM; Barrow DL; Samuels OB
    Neurocrit Care; 2013 Aug; 19(1):48-55. PubMed ID: 22847395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.